Vertex Pharmaceuticals Inc. (VRTX) News Headlines

▮ More

Date

Headline

8/4/2022 4:42:31 PM Vertex Pharmaceuticals Inc. Reveals Rise In Q2 Bottom Line

8/4/2022 4:41:47 PM Vertex Pharmaceuticals Lifts FY22 Product Revenue Outlook

8/4/2022 4:40:02 PM Vertex Pharmaceuticals Inc. (VRTX) Has Raised Its FY22 Revenue Estimate To $8.6 to $8.8 Bln From $8.4 to $8.6 Bln

8/4/2022 4:14:34 PM Vertex Pharma Q2 EPS $3.13 Vs. $0.26 Year Ago

8/4/2022 3:00:17 PM Vertex Pharmaceuticals Q2 22 Earnings Conference Call At 4:30 PM ET

7/11/2022 8:25:59 AM Vertex Pharma To Acquire ViaCyte For $320 Mln In Cash

7/11/2022 8:05:10 AM Vertex To Acquire ViaCyte For $320 Mln In Cash

7/5/2022 8:10:22 AM Vertex Pharma Says FDA Lifts Clinical Hold On Phase 1/2 Trial Of VX-880 To Treat Type 1 Diabetes

7/5/2022 8:02:54 AM Vertex : FDA Lifts Clinical Hold On VX-880 Phase 1/2 Trial For Treatment Of Type 1 Diabetes

6/15/2022 3:00:59 PM Vertex Pharma To Present At Goldman Sachs Global Healthcare Conference; Webcast At 4:20 PM ET

6/8/2022 8:37:06 AM Vertex Pharma: FDA Grants Inaxaplin Breakthrough Therapy Designation

6/8/2022 8:03:42 AM Vertex's Inaxaplin Granted Breakthrough Therapy Designation By FDA And Priority Medicines Designation By EMA

6/2/2022 10:21:57 AM Vertex And CRISPR Announce Acceptance Of Late-Breaking Abstract For CTX001 At 2022 Annual EHA Congress

5/31/2022 8:07:48 AM Vertex To Present New Data On VX-880 Clinical Trial

5/5/2022 4:26:21 PM Vertex Pharma Q1 EPS $2.96 Vs. $2.49 Year Ago

5/5/2022 4:08:55 PM Vertex Pharmaceuticals Inc. Q1 Profit Increases, beats estimates

5/5/2022 3:00:09 PM Vertex Pharmaceuticals Q1 22 Earnings Conference Call At 4:30 PM ET

5/2/2022 9:22:34 AM Vertex Pharma Issues Updates On Phase 1/2 Trial Of VX-880; FDA Places Clinical Hold

5/2/2022 8:34:56 AM Vertex Updates On Phase 1/2 Clinical Trial Of VX-880 For Treatment Of Type 1 Diabetes

3/25/2022 8:48:51 AM Vertex Gets Approval In Canada For Expanded Use Of Cystic Fibrosis Drug Kalydeco